Neurogene (NGNE) Reports In-Line Q3 EPS

Neurogene (NASDAQ: NGNE) reported Q3 EPS of ($1.19), in-line with the analyst estimate of ($1.19).

For earnings history and earnings-related data on Neurogene (NGNE) click here.

You May Also Be Interested In

• Stay long AI-capex winners into the peak, Stifel says despite bubble fears
• Crown Crafts (CRWS) Reports Q4 EPS of $0.03
• Litchfield Hills Starts NextPlat (NXPL) at Buy